Syngene International Current Share Price | Syngene International Stock Screener
SYNGENE
Healthcare Technology
Syngene International Current Stock Price Today
Live Share Price NSE
₹369.05
▼
-11.15 (-2.93%)
Live Share Price BSE
₹369.25
▼
-10.70 (-2.82%)
As of September 18, 2026, the live Syngene International share price (NSE: SYNGENE) is ₹369.05 on NSE and ₹369.25 on BSE, down 2.93% from the previous close, with shares trading between ₹366.65 and ₹384.00 in today's trading session, and a 52-week range of ₹369.05–₹663.85.
Browse SYNGENE balance sheet details to support your investment research.
Use the Syngene International stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Syngene International Market Cap
₹15,307.13 Cr.
SYNGENE P/E Ratio (TTM)
69.95
Syngene International P/B Ratio
3.20
EPS (TTM)
₹7.87
Dividend Yield
0.33%
Debt to Equity
0.11
SYNGENE 52 Week High
₹663.85
Syngene International 52 Week Low
₹369.05
Operating Margin
11.00%
Profit Margin
-1.18%
SYNGENE Revenue (TTM)
₹761.00
EBITDA
₹103.00
Net Income
₹-9.00
Total Assets
₹7,055.00
Total Equity
₹4,839.00
Syngene International Current Share Price Chart
Track the current Syngene International share price and stock price with an interactive chart. Analyse SYNGENE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Syngene International stock quote in one place.
Syngene International Company Profile - Fundamental Screener
Screen Syngene International company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SYNGENE shares.
Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene...more
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
Chairperson/CEO
Kiran Mazumdar Shaw
ISIN
INE398R01022
Website
https://www.syngeneintl.com
Syngene International Balance Sheet Screener
Screen SYNGENE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 7,055 | 6,796 | 6,152 | 5,831 | 5,564 | 4,883 | 4,163 | 3,704 | 3,189 |
| Current Assets | 2,143 | 2,287 | 1,959 | 2,425 | 2,206 | 1,807 | 1,613 | 1,764 | 1,720 |
| Fixed Assets | 3,000 | 2,802 | 2,850 | 2,667 | 2,393 | 2,201 | 2,020 | 1,377 | 1,030 |
| Liabilities | |||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 663 | 673 | 750 | 1,025 | 1,037 | 929 | 448 | 607 | 685 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 4,839 | 4,727 | 4,258 | 3,618 | 3,298 | 2,821 | 2,176 | 1,968 | 1,720 |
| Share Capital | 403 | 403 | 402 | 401 | 401 | 400 | 400 | 200 | 200 |
| Reserves & Surplus | 4,436 | 4,324 | 3,856 | 3,217 | 2,897 | 2,421 | 1,776 | 1,768 | 1,520 |
Syngene International Income Statement Screener - Profit & Revenue Analysis
Screen Syngene International income statement and profit fundamentals.
Analyze SYNGENE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Syngene International share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 761 | 1,059 | 933 | 926 | 892 | 1,037 | 933 | 840 | 908 | 962 | 1,017 | 832 | 932 | 883 | 773 |
| Expenses | 659 | 739 | 779 | 711 | 668 | 674 | 600 | 620 | 646 | 660 | 680 | 596 | 663 | 626 | 508 |
| EBITDA | 103 | 320 | 154 | 215 | 224 | 363 | 333 | 220 | 261 | 302 | 337 | 236 | 268 | 257 | 265 |
| Operating Profit % | 11.00% | 29.00% | 15.00% | 22.00% | 24.00% | 34.00% | 35.00% | 22.00% | 27.00% | 30.00% | 32.00% | 26.00% | 27.00% | 27.00% | 33.00% |
| Depreciation | 112 | 112 | 114 | 117 | 111 | 106 | 111 | 107 | 111 | 109 | 96 | 102 | 105 | 108 | 80 |
| Interest | 10 | 12 | 12 | 13 | 12 | 16 | 13 | 12 | 13 | 12 | 10 | 11 | 13 | 11 | 6 |
| Profit Before Tax | -19 | 196 | 28 | 85 | 101 | 241 | 209 | 101 | 137 | 181 | 231 | 123 | 151 | 138 | 179 |
| Tax | -10 | 48 | 13 | 18 | 15 | 57 | 20 | 26 | 31 | 50 | 52 | 30 | 34 | 27 | 31 |
| Net Profit | -9 | 148 | 15 | 67 | 87 | 183 | 189 | 76 | 106 | 131 | 179 | 93 | 117 | 112 | 148 |
| EPS | -0.22 | 3.68 | 0.37 | 1.67 | 2.16 | 4.56 | 4.70 | 1.89 | 2.64 | 3.27 | 4.36 | 2.33 | 2.90 | 2.78 | 3.71 |
Syngene International Cash Flow Screener - Liquidity Fundamentals
Screen SYNGENE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 915 | 1,168 | 1,042 | 824 | 581 | 701 | 677 | 630 | 446 |
| Investing Activities | -839 | -744 | -495 | -653 | -611 | -629 | -424 | -646 | -349 |
| Financing Activities | -215 | -142 | -551 | -343 | -31 | 58 | -226 | -72 | -79 |
| Net Cash Flow | -139 | 281 | -4 | -172 | -62 | 130 | 28 | -88 | 18 |
Syngene International Shareholding Pattern Screener
See Syngene International shareholding pattern with promoter, FII, and DII holdings.
Check Syngene International promoter holding and ownership changes for SYNGENE on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.59% | 52.68% | 52.68% | 52.68% | 52.68% | 52.74% | 52.74% | 54.72% |
| FII Holding | 11.82% | 13.90% | 14.96% | 16.31% | 16.50% | 19.47% | 20.64% | 20.72% |
| DII Holding | 28.02% | 26.44% | 25.84% | 24.62% | 24.05% | 21.50% | 19.53% | 17.48% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.14% | 5.51% | 5.37% | 5.28% | 5.59% | 5.08% | 5.59% | 5.45% |
| Other Holding | 1.44% | 1.46% | 1.15% | 1.10% | 1.18% | 1.21% | 1.50% | 1.62% |
| Shareholder Count | 142,277 | 135,605 | 131,750 | 136,061 | 142,310 | 125,090 | 128,806 | 107,338 |
Syngene International Share Dividend Screener - Share Yield Analysis
Check Syngene International dividend history with payout and yield data.
View Syngene International dividend details including ex-dates and amounts for SYNGENE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.25 | 0.33% |
| 2025-March | ₹1.25 | 0.32% |
| 2024-March | ₹1.25 | 0.17% |
| 2023-March | ₹1.25 | 0.18% |
| 2022-March | ₹1.00 | 0.17% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.50 | 0.21% |
| 2018-March | ₹1.00 | 0.34% |
| 2017-March | ₹1.00 | 0.33% |
Syngene International Stock Index Membership
See which indices include Syngene International stock.
Check SYNGENE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MSL400
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY M150 QLTY50
NIFTY MIDCAP 150
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
NIFTYM150MOMNTM50
Syngene International Market Events Screener - Corporate Actions
Get Syngene International corporate actions including splits, bonuses, and buybacks.
Check Syngene International stock events that may affect SYNGENE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-29 | 2026-07-29 | Quarterly Result Announcement | NA | -3.18% |
| 2026-07-29 | 2026-07-29 | Annual General Meeting | NA | -6.99% |
| 2026-06-25 | 2026-06-26 | Dividend | ₹ 1.25 /share | -0.89% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 9.19% |
| 2026-01-22 | 2026-01-22 | Quarterly Result Announcement | NA | -8.51% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 2.52% |
| 2025-07-23 | 2025-07-23 | Annual General Meeting | NA | -8.05% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 6.63% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 1.25 /share | -12.18% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 5.45% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -3.68% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -5.14% |
| 2024-07-24 | 2024-07-24 | Annual General Meeting | NA | 8.09% |
| 2024-06-28 | 2024-06-28 | Dividend | ₹ 1.25 /share | 1.73% |
| 2023-06-30 | 2023-06-30 | Dividend | ₹ 0.50 /share | 21.36% |
Syngene International Competitors Screener - Peer Comparison
Screen SYNGENE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 15,307 | 69.95 | 3,809 | 2.56% | 317 | 34.74 |
| Indegene | 13,879 | 34.74 | 3,583 | 21.58% | 401 | 53.06 |
| Suven Life Sciences | 9,813 | -28.45 | 21 | 19.32% | -276 | 49.69 |
| Vimta Labs | 2,791 | 35.09 | 322 | 0.22% | 41 | 50.83 |
| TAKE | 274 | 20.41 | 61 | 497.06% | 4 | 47.08 |
| Bilcare | 230 | -34.41 | 734 | -9.05% | -21 | 57.83 |
| Jeevan Scientific Technology | 163 | 32.06 | 62 | 29.56% | 2 | 63.29 |
| Adeshwar Meditex | 22 | 33.09 | 56 | -33.21% | 1 | 50.09 |
| Vanta Bioscience | 15 | 137.20 | 2 | -13.33% | 0 | 14.70 |
Syngene International Company Announcements - News Screener
Screen SYNGENE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-17 | Communication Regarding Remittance Of Final Dividend For The FY 2025-26 | - |
| 2026-09-01 | Grant Of Performance Share Units Under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 (Plan) | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-29 | Results - Financial Results For Quarter Ended June 30 2026 | - |
| 2026-07-29 | Board Meeting Outcome for Outcome Of The Board Meeting Held On July 29 2026 | - |
| 2026-07-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |